Premium Nahrungsergänzungsmittel | artgerecht

hs-CRP: Meaning, Values & Cardiovascular Risk

hs-CRP is a highly sensitive blood test measuring C-reactive protein at low levels, used to detect chronic inflammation and assess cardiovascular disease risk.

Regular tips about health Regular tips about health

Things worth knowing about "hs-CRP"

hs-CRP is a highly sensitive blood test measuring C-reactive protein at low levels, used to detect chronic inflammation and assess cardiovascular disease risk.

What is hs-CRP?

hs-CRP stands for high-sensitivity C-reactive protein. It is a laboratory diagnostic test capable of detecting very low concentrations of the inflammation marker C-reactive protein (CRP) in the blood. Unlike the standard CRP test, which is primarily used to diagnose acute infections or inflammatory conditions, the hs-CRP test is specifically designed to identify low-grade chronic inflammation that is associated with an increased risk of cardiovascular disease.

What is C-reactive Protein (CRP)?

C-reactive protein is a protein produced by the liver in response to inflammatory signals, particularly the cytokine interleukin-6 (IL-6). It belongs to a group of proteins known as acute-phase reactants, which increase rapidly in response to tissue damage, infections, or systemic inflammation. CRP plays a role in activating the immune system and facilitating the clearance of damaged cells and foreign pathogens.

Difference Between CRP and hs-CRP

The key difference lies in measurement sensitivity:

The standard CRP test typically measures values from approximately 3–10 mg/L and is used to detect acute infections or inflammatory diseases.
The hs-CRP test can accurately measure values in the range of 0.1 to 10 mg/L, making it significantly more sensitive.

This enhanced sensitivity makes the hs-CRP test particularly valuable for assessing cardiovascular risk in apparently healthy individuals who show no obvious signs of acute illness.

Clinical Significance and Applications

The hs-CRP test is primarily used to assess cardiovascular disease risk. Research has consistently shown that chronically elevated hs-CRP levels are associated with a higher risk of:

Heart attack (myocardial infarction)
Stroke
Peripheral artery disease (PAD)
Type 2 diabetes mellitus

The test is frequently used alongside other risk markers such as LDL cholesterol to provide a more comprehensive picture of an individual's cardiovascular risk profile.

Reference Values and Interpretation

The American Heart Association (AHA) and the Centers for Disease Control and Prevention (CDC) recommend the following cardiovascular risk classification based on hs-CRP levels:

Low risk: hs-CRP < 1.0 mg/L
Intermediate risk: hs-CRP 1.0 – 3.0 mg/L
High risk: hs-CRP > 3.0 mg/L

Values exceeding 10 mg/L typically indicate an acute infection or inflammatory condition and should not be used for cardiovascular risk assessment. In such cases, the test should be repeated once the acute illness has resolved.

Diagnosis: When is hs-CRP Measured?

An hs-CRP test is performed as part of a standard blood draw. It is particularly useful in the following situations:

Individuals with intermediate cardiovascular risk where the decision to initiate medical therapy is unclear.
Monitoring inflammatory status in patients with metabolic disorders.
Follow-up assessments in patients with known cardiovascular disease or risk factors.

Fasting is not strictly required for the hs-CRP test, but it is often recommended when the test is combined with a lipid panel (e.g., total cholesterol, LDL, HDL) for a complete cardiovascular workup.

Factors That Influence hs-CRP Levels

Several lifestyle and medical factors can affect hs-CRP levels and should be considered when interpreting results:

Factors that raise hs-CRP: smoking, obesity, physical inactivity, poor sleep quality, chronic psychological stress, diabetes, hypertension, and an unhealthy diet
Factors that lower hs-CRP: regular physical activity, a Mediterranean-style diet, weight loss, statin therapy, omega-3 fatty acids, and aspirin

hs-CRP and Treatment Decisions

In clinical practice, an elevated hs-CRP value can support the decision to initiate statin therapy (cholesterol-lowering medication), even when LDL cholesterol levels appear normal. The landmark JUPITER trial demonstrated that patients with normal LDL levels but elevated hs-CRP could benefit significantly from rosuvastatin therapy, reducing the risk of major cardiovascular events. This finding substantially elevated the clinical relevance of hs-CRP testing in preventive cardiology.

References

Ridker PM et al. - Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein (JUPITER Trial). New England Journal of Medicine, 2008.
Pearson TA et al. - Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice. Circulation, American Heart Association, 2003.
World Health Organization (WHO) - Cardiovascular Diseases: Risk Factors and Prevention. WHO Global Report, 2021.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.